Glycotope GmbH
🇩🇪Germany
Clinical Trials
25
Active:14
Completed:11
Trial Phases
2 Phases
Phase 1:16
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 1
16 (84.2%)Phase 2
3 (15.8%)Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors
Phase 1
Completed
- Conditions
- Solid Tumor, Adult
- First Posted Date
- 2017-12-04
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- Glycotope GmbH
- Target Recruit Count
- 50
- Registration Number
- NCT03360734
- Locations
- 🇪🇸
Glycotope-contracted research facility, Barcelona, Spain
CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer
Phase 2
Completed
- Conditions
- Carcinoma, Squamous Cell of Head and Neck
- Interventions
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Glycotope GmbH
- Target Recruit Count
- 240
- Registration Number
- NCT02052960
- Locations
- 🇪🇸
Glycotope-contracted Research Facility, Valencia, Spain
🇩🇪Glycotope-contracted Research Facillity, Hannover, Germany
🇮🇹Gycotope-contracted Research Facility, Milan, Italy
PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer
Phase 2
Completed
- Conditions
- Primary Peritoneal CancerFallopian Tube CancerOvarian Epithelial Cancer Recurrent
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-07-15
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Glycotope GmbH
- Target Recruit Count
- 216
- Registration Number
- NCT01899599
- Locations
- 🇬🇧
Investigator, Sutton, United Kingdom
Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®
- First Posted Date
- 2013-02-18
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Glycotope GmbH
- Target Recruit Count
- 267
- Registration Number
- NCT01794208
- Locations
- 🇭🇺
Glycotope Investigational Site, Tapolca, Hungary
🇩🇪Glycotope Investigational Medical Director, Bielefeld, Germany
Multiple Dose FSH-GEX(TM) in Healthy Volunteers
Phase 1
Completed
- Conditions
- Female Infertility
- Interventions
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Glycotope GmbH
- Target Recruit Count
- 57
- Registration Number
- NCT01477073
- Locations
- 🇳🇱
Glycotope Investigational Site, Groningen, Netherlands
- Prev
- 1
- 2
- Next
News
No news found